
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/09/2025 | Q1 | -- | $20.7M | $1.07 | -- | -- |
12/31/2024 | Q4 | -- | $20.4M | $1.19 | -- | -- |
11/08/2024 | Q3 | -- | $20.2M | $1.10 | -- | -- |
08/08/2024 | Q2 | -- | $20.1M | $1.15 | -- | -- |
05/09/2024 | Q1 | -- | $19.9M | $0.97 | -- | -- |
12/31/2023 | Q4 | -- | $19.7M | $0.64 | -- | -- |
11/09/2023 | Q3 | -- | -- | $0.61 | -- | -- |
08/08/2023 | Q2 | -- | -- | $0.62 | -- | -- |
05/09/2023 | Q1 | -- | -- | $0.49 | -- | -- |
01/19/2023 | Q4 | -- | -- | $0.59 | -- | -- |
09/30/2022 | Q3 | -- | -- | $0.27 | -- | -- |
08/05/2022 | Q2 | -- | -- | $0.07 | -- | -- |
05/06/2022 | Q1 | -- | -- | $0.09 | -- | -- |
12/31/2021 | Q4 | -- | -- | -$0.80 | -- | -- |
11/08/2021 | Q3 | -- | -- | -$0.02 | -- | -- |
08/06/2021 | Q2 | -- | -- | $0.15 | -- | -- |
05/07/2021 | Q1 | -- | -- | -$0.08 | -- | -- |
12/31/2020 | Q4 | -- | -- | -$0.27 | -- | -- |
11/06/2020 | Q3 | -- | -- | -$0.12 | -- | -- |
08/07/2020 | Q2 | -- | -- | $0.40 | -- | -- |
05/08/2020 | Q1 | -- | -- | $0.37 | -- | -- |
12/31/2019 | Q4 | -- | -- | $0.51 | -- | -- |
11/08/2019 | Q3 | -- | -- | $0.37 | -- | -- |
08/07/2019 | Q2 | -- | -- | $0.48 | -- | -- |
05/08/2019 | Q1 | -- | -- | $0.40 | -- | -- |
12/31/2018 | Q4 | -- | -- | $0.42 | -- | -- |
11/08/2018 | Q3 | -- | -- | $0.18 | -- | -- |
08/08/2018 | Q2 | -- | -- | $0.01 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.50 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.45 | -- | -- |
11/08/2017 | Q3 | -- | -- | $0.23 | -- | -- |
08/08/2017 | Q2 | -- | -- | $0.66 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.50 | -- | -- |
12/31/2016 | Q4 | -- | -- | $0.40 | -- | -- |
11/04/2016 | Q3 | -- | -- | $0.32 | -- | -- |
08/05/2016 | Q2 | -- | -- | $0.26 | -- | -- |
03/31/2016 | Q1 | -- | -- | $0.32 | -- | -- |
12/31/2015 | Q4 | -- | -- | $0.31 | -- | -- |
09/30/2015 | Q3 | -- | -- | $0.28 | -- | -- |
New England Realty Associates LP reported $20.7M worth of top line sales in its most recent quarter.
New England Realty Associates LP announced earnings per share of $1.07 which represents a beat of analyst forecast a -- per share.
New England Realty Associates LP reported $14.3M that represents $4.05 per share over the last quarter.
New England Realty Associates LP's earnings are forecast to grow from $4.42 per share to -- per share next year representing an increase of --.
New England Realty Associates LP's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.